Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Equity Ratio (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Equity Ratio for 5 consecutive years, with 0.89 as the latest value for Q3 2020.

  • Quarterly Equity Ratio rose 2054.41% to 0.89 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 0.89 through Sep 2020, up 2054.41% year-over-year, with the annual reading at 0.62 for FY2019, 8621.93% down from the prior year.
  • Equity Ratio for Q3 2020 was 0.89 at Forte Biosciences, up from 0.88 in the prior quarter.
  • The five-year high for Equity Ratio was 0.89 in Q3 2020, with the low at 3.88 in Q1 2017.
  • Average Equity Ratio over 5 years is 0.16, with a median of 0.26 recorded in 2018.
  • The sharpest move saw Equity Ratio crashed 8621.93% in 2019, then skyrocketed 3039.5% in 2020.
  • Over 5 years, Equity Ratio stood at 3.52 in 2016, then soared by 121.94% to 0.77 in 2017, then crashed by 100.92% to 0.01 in 2018, then plummeted by 8621.93% to 0.62 in 2019, then skyrocketed by 243.55% to 0.89 in 2020.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.89, 0.88, and 0.36 for Q3 2020, Q2 2020, and Q1 2020 respectively.